Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
Meng Wu, Jennifer A. Bennett, Pankti Reid, Gini F. Fleming, Katherine C. Kurnit
Abstract
•Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown.•Pembrolizumab successfully treated a patient with metastatic SCC.•Patients on pembrolizumab should be monitored for immune-related adverse events.
Topics & Concepts
PembrolizumabMedicineOvarian carcinomaOncologyOvaryInternal medicineImmunotherapyPathologyOvarian cancerCancerOvarian cancer diagnosis and treatmentCancer Immunotherapy and BiomarkersPolyomavirus and related diseases